We’re delighted to announce that Mark Juniper has been appointed as the West of England AHSN’s new Medical Director.
Mark will be joining the AHSN on 1 October 2022 on a three-year, part-time secondment from Great Western Hospitals NHS Foundation Trust, where he is Consultant Physician.
With a long track record in supporting the work of the West of England AHSN, Mark has been a member of our Patient Safety Collaborative Board since it was first established. He has also been one of our clinical leads since 2020, with a particular involvement in our respiratory work programmes.
Mark was appointed as a consultant in Respiratory and Intensive Care Medicine at the Great Western Hospital in Swindon in 2000. He has held various leadership roles there including Associate Medical Director and Clinical Lead for Quality. Mark is also Clinical Coordinator for the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) and the Chair of the Quality Improvement Committee at the British Thoracic Society.
On accepting the post, Mark said: “The AHSN has done so much to improve patient safety and care in general since it was established. There will be many more opportunities to work with organisations across the West of England to improve care. I’m really excited to have been given this opportunity to help make the work we do as effective as possible. I’ve always enjoyed working with the whole AHSN team and look forward to doing more great work together.”
Our current Medical Director, Anne Pullyblank will be leaving the AHSN on 30 September. Anne will continue in post with North Bristol NHS Trust as Consultant Colorectal Surgeon and will retain a leadership role in the next phase of the West of England AHSN’s PreciSSIon programme, which will adopt and spread a bundle of interventions in caesarean section surgery.
Natasha Swinscoe, Chief Executive of the West of England AHSN, commented: “I am thrilled that Mark will be joining our senior team in the autumn as our new Medical Director. Through his support for our work to date, it is clear that Mark is passionate about quality improvement and leadership in healthcare.
“Anne Pullyblank certainly leaves big shoes to fill, but Mark is an excellent successor and will continue her legacy of promoting the role of quality improvement, innovation and patient safety across our programme of work with our member and partner organisations.”
Posted on September 5, 2022
